Tag: extracellular vesicles
-
Fat May Secretly Fuel Alzheimer’s: Obesity Tied to Brain Plaque via Adipose Vesicles
Obesity, tiny messengers, and a potential Alzheimer’s link In a pioneering study from Houston Methodist, researchers propose that adipose-derived extracellular vesicles—tiny, cell-to-cell messengers circulating in the body—may signal the brain to form amyloid-β plaques, a hallmark of Alzheimer’s disease. Published on October 2 in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, the work…
-
Fat Signals: Adipose-Derived Vesicles May Fuel Alzheimer’s in Obesity
Fat signals and a hidden link to Alzheimer’s disease A landmark, first-of-its-kind study from Houston Methodist suggests that adipose-derived extracellular vesicles—tiny, membrane-bound messengers released by fat tissue—can influence the formation of amyloid-β plaques, a hallmark of Alzheimer’s disease. The research, published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association on October 2, points…
-
Fat-Derived Vesicles May Secretly Fuel Alzheimer’s: New Houston Methodist Findings
Fat-Dat-Derived Vesicles and Alzheimer’s: A Hidden Link Between Fat and the Brain A first-of-its-kind study from Houston Methodist uncovers a potential mechanism by which adipose tissue—body fat—may influence the brain’s vulnerability to Alzheimer’s disease. The researchers show that adipose-derived extracellular vesicles (EVs), tiny cell-to-cell messengers, carry lipid cargo that can signal the aggregation of amyloid-β…
-
World-first LAF assay reveals hidden interactions in blood
World-first LAF assay: a new lens on blood chemistry A team at the University of Queensland’s Australian Institute for Bioengineering and Nanotechnology (AIBN) has unveiled a world-first assay that rapidly measures interactions between nanoscale particles in the bloodstream. The lipoprotein association fluorometry (LAF) technique can deliver results in about one hour, a dramatic improvement over…
-
World-first LAF assay reveals hidden blood particle interactions
Breakthrough in Blood Biology: The LAF Assay A team at the Australian Institute for Bioengineering and Nanotechnology (AIBN) has unveiled a world-first assay that can measure interactions between tiny particles in the bloodstream in just one hour. Lipoprotein association fluorometry, or LAF, was developed by PhD student Raluca Ghebosu under the supervision of AIBN’s Joy…
-
World-first LAF Assay Reveals Hidden Blood Interactions in Cancer
World-first LAF assay accelerates cancer research A groundbreaking technique developed at the Australian Institute for Bioengineering and Nanotechnology (AIBN) is redefining how scientists study the bloodstream’s tiniest particles. Lipoprotein Association Fluorometry (LAF) is a world-first assay that can rapidly measure interactions between extracellular vesicles (EVs) and lipoproteins—crucial steps in understanding how cancers develop, spread, and…